loading
Skye Bioscience Inc stock is traded at $1.40, with a volume of 282.21K. It is down -2.10% in the last 24 hours and down -44.22% over the past month.
See More
Previous Close:
$1.43
Open:
$1.38
24h Volume:
282.21K
Relative Volume:
1.51
Market Cap:
$43.36M
Revenue:
-
Net Income/Loss:
$-21.24M
P/E Ratio:
-1.6708
EPS:
-0.8379
Net Cash Flow:
$-22.47M
1W Performance:
-33.96%
1M Performance:
-44.22%
6M Performance:
-60.89%
1Y Performance:
+0.00%
1-Day Range:
Value
$1.26
$1.43
1-Week Range:
Value
$1.26
$2.25
52-Week Range:
Value
$1.26
$17.65

Skye Bioscience Inc Stock (SKYE) Company Profile

Name
Name
Skye Bioscience Inc
Name
Phone
(858) 410-0266
Name
Address
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
SKYE's Discussions on Twitter

Compare SKYE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
 icon
SKYE
Skye Bioscience Inc.
3.10 12.89M 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.64 372.90M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.1672 352.85M 2.07B -1.42B -1.37B -0.6765
 icon
MOBBW
Mobilicom Limited Warrants
0.34 278.60M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
11.05 144.42M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.20 137.80M 0 0 0 0.00

Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-28-25 Initiated William Blair Outperform
Sep-30-24 Initiated Scotiabank Sector Outperform
Sep-10-24 Initiated JMP Securities Mkt Outperform
Jul-09-24 Initiated Craig Hallum Buy
May-23-24 Initiated Cantor Fitzgerald Overweight
Apr-12-24 Initiated Oppenheimer Outperform
View All

Skye Bioscience Inc Stock (SKYE) Latest News

pulisher
Apr 02, 2025

Charles Schwab Investment Management Inc. Has $176,000 Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Charles Schwab Investment Management Inc. Grows Stock Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

10,142 Shares in Skye Bioscience, Inc. (NASDAQ:SKYE) Acquired by Virtu Financial LLC - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Invests $29,000 in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Apr 02, 2025
pulisher
Mar 30, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Consensus Rating of “Buy” from Analysts - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives $18.00 Average Price Target from Analysts - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Mar 28, 2025
pulisher
Mar 25, 2025

Skye Bioscience, Inc. (PNK:SKYE) Q4 2024 Earnings Call Transcript - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

Skye Bioscience (NASDAQ:SKYE) Receives Outperform Rating from William Blair - MarketBeat

Mar 25, 2025
pulisher
Mar 25, 2025

Skye Bioscience promotes Tu Diep to COO post - The Pharma Letter

Mar 25, 2025
pulisher
Mar 25, 2025

Craig Hallum Issues Pessimistic Forecast for Skye Bioscience (NASDAQ:SKYE) Stock Price - MarketBeat

Mar 25, 2025
pulisher
Mar 24, 2025

Skye Bioscience (NASDAQ:SKYE) Announces Quarterly Earnings Results - MarketBeat

Mar 24, 2025
pulisher
Mar 23, 2025

Skye Bioscience’s SWOT analysis: novel obesity drug stock faces pivotal year - Investing.com Canada

Mar 23, 2025
pulisher
Mar 23, 2025

Skye Bioscience’s (SKYE) “Outperform” Rating Reiterated at William Blair - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Skye Bioscience’s SWOT analysis: novel obesity drug stock faces pivotal year By Investing.com - Investing.com South Africa

Mar 22, 2025
pulisher
Mar 22, 2025

SKYE Stock Price and Chart — NASDAQ:SKYE - TradingView

Mar 22, 2025
pulisher
Mar 21, 2025

Skye Bioscience’s Positive Earnings Call Highlights Nimacimab Progress - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Skye Bioscience (SKYE) and Bristol-Myers Squibb (BMY) - The Globe and Mail

Mar 21, 2025
pulisher
Mar 21, 2025

Citizens JMP reiterates Skye Bioscience at market outperform By Investing.com - Investing.com Canada

Mar 21, 2025
pulisher
Mar 21, 2025

Citizens JMP reiterates Skye Bioscience at market outperform - Investing.com India

Mar 21, 2025
pulisher
Mar 21, 2025

Skye Bioscience (NASDAQ:SKYE) Shares Down 31% – Time to Sell? - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Skye Bioscience (NASDAQ:SKYE) Stock Price Down 31% – Time to Sell? - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Skye Bioscience Reports 2024 Financial Results and Trial Progress - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

Skye Bioscience accelerates nimacimab clinical trial timeline with early enrollment and extended treatment period - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

Earnings call transcript: Skye Bioscience Q4 2024 highlights financials, product progress - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience Inc. (SKYE) reports earnings - Quartz

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience Reports Fourth Quarter And Full Year 2024 Financial Results And Provides Business Update - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Skye's Obesity Drug Trial Hits Major Milestone with Strong Financial Backing - StockTitan

Mar 20, 2025
pulisher
Mar 18, 2025

Skye Bioscience Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView

Mar 18, 2025
pulisher
Mar 17, 2025

SKYE BIOSCIENCE Earnings Preview: Recent $SKYE Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 17, 2025
pulisher
Mar 14, 2025

Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025 - The Manila Times

Mar 14, 2025
pulisher
Mar 14, 2025

Skye Bioscience to Host Conference Call on March 20, 2025, to Discuss Q4 and Full-Year 2024 Financial Results - Nasdaq

Mar 14, 2025
pulisher
Mar 14, 2025

Skye Bioscience Q4 Earnings: Obesity Treatment Pioneer Reveals 2024 Financial Performance - StockTitan

Mar 14, 2025
pulisher
Mar 05, 2025

Brokerages Set Skye Bioscience, Inc. (NASDAQ:SKYE) Price Target at $18.67 - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Given Average Rating of "Buy" by Analysts - MarketBeat

Mar 04, 2025
pulisher
Mar 04, 2025

Skye Bioscience (NASDAQ:SKYE) Trading Down 2%Should You Sell? - MarketBeat

Mar 04, 2025
pulisher
Mar 04, 2025

Skye Bioscience (NASDAQ:SKYE) Coverage Initiated at William Blair - MarketBeat

Mar 04, 2025
pulisher
Mar 02, 2025

Skye Bioscience (NASDAQ:SKYE) Research Coverage Started at William Blair - Defense World

Mar 02, 2025

Skye Bioscience Inc Stock (SKYE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Cap:     |  Volume (24h):